QIAGEN launches the DNeasy PowerSoil Pro Kit to advance microbiome characterization in soils

QIAGEN welcomes WHO’s Essential Diagnostics List which includes QuantiFERON-TB Gold

Disclosure according to Article 5 Section (1) and (6) of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052/ Share Repurchase

QIAGEN reports results for first quarter 2018

QIAGEN announces FDA approval of PartoSure

QIAGEN announces European launch of QIAstat-Dx, a next generation platform for syndromic insights

QIAGEN launches AdnaTest liquid biopsy kits in prostate and lung cancer

QIAGEN’s QuantiFERON-TB® Gold Plus gains endorsement for latent tuberculosis screening in immigration

QIAGEN and Natera partner to develop cutting-edge genetic testing assays for use on QIAGEN’s GeneReader NGS System

QIAGEN launches CE-IVD assay to detect Trichomonas vaginalis in both female and male patients on the QIAsymphony RGQ platform